Off-Label Dissemination Occurring Without FDA Okay After Feb. 16 WLF Ruling
This article was originally published in The Gray Sheet
Executive Summary
Medical device and pharmaceutical firms that choose to aggressively disseminate off-label information following a recent court ruling in Washington Legal Foundation v. FDA are at a higher risk for product liability claims, Washington attorney Alan Bennett, Fox Bennett and Turner, cautioned March 3 at a WLF-sponsored press briefing.